lilly direct pharmacy tirzepatide Eli to sell Zepbound directly to consumers without insurance coverage Lilly releases Zepbound® (tirzepatide) single-dose

Need exact syringe measurements

doi:10.1001/jamapsychiatry.2025.2332 (article) FOR ACADEMY MEMBERS: NEW ERA OF WEIGHT LOSS MEDICATIONS New Era of Weight Loss Medications [FOR ACADEMY MEMBERS ONLY] Want the latest research insights delivered straight to your inbox

Reduced weight and enhanced mobility mean patients can participate more fully in everyday activities

Data are presented as mean SD

Importantly, semaglutide carries a boxed warning for risk of thyroid C-cell tumors, and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Major pharmacy benefit managers (PBMs) like CVS Caremark prefer it over competitors